NCT02986295 (SMARTDESK-MX) is a clinical trial of BioMimeTM Stent, Ultimaster® Stent in Ischemic Heart Disease, sponsored by Hyeon-Cheol Gwon.

Who is sponsoring NCT02986295?

NCT02986295 is sponsored by Hyeon-Cheol Gwon.

What drugs are being tested in NCT02986295?

Interventions in NCT02986295: BioMimeTM Stent, Ultimaster® Stent.

What condition does NCT02986295 study?

NCT02986295 studies Ischemic Heart Disease.

Is NCT02986295 still recruiting?

NCT02986295 is currently status unknown. Last updated 9 February 2018.

Last reviewed 2018-02-09 · How we verify

NCT02986295: SMARTDESK-MX

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Registry in Korea: BioMimeTM Stent, Ultimaster® Stent vs. Xience® Stent

Status unknown Last updated 9 February 2018

What this trial tests

trial testing BioMimeTM Stent, Ultimaster® Stent in Ischemic Heart Disease in 2,000 participants. Status unknown.

Timeline

1 April 2016

Primary endpoint
31 January 2019

31 January 2021

Quick facts

Lead sponsor	Hyeon-Cheol Gwon
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	2,000
Start date	1 April 2016
Primary completion	31 January 2019
Estimated completion	31 January 2021
Sites	1 location across South Korea

Drugs / interventions tested

BioMimeTM Stent, Ultimaster® Stent

Conditions studied

Ischemic Heart Disease — all drugs for Ischemic Heart Disease →

Sponsor

Hyeon-Cheol Gwon

Who can join

19 and older, any sex, with Ischemic Heart Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Comparison of safety and long-term effects of BioMimeTM stent and Ultimaster® stent with Xience® stent

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Ischemic Heart Disease

Currently open trials in the same condition.

NCT07399002 — LONG NAGOMI™ PMCF STUDY · recruiting
NCT07083557 — Routine Validation and Reproducibility Testing of Laboratory Assays and Research Techniques Used for Endocrine, Cardiome · recruiting
NCT06712862 — A Clinical Study of Evaluating Myocardial Viability in Ischemic Heart Disease with Integrated 18F-FDG PET/MR · recruiting
NCT07009418 — Smart Angioplasty Research Team-Coronary CT Angiography Versus Standard Care as Follow-up Strategies in High-Risk Patien · NA · recruiting
NCT06891456 — Pulsed Field Ablation for Post-Infarction Ventricular Tachycardia · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02986295 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Hyeon-Cheol Gwon
Last refreshed: 9 February 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02986295.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing